One on One Video with ICON - Kim Boericke
Thought Leader:
Kim Boericke, ICON Commercialization and Outcomes Services
Kim Boericke, President, ICON Commercialization and Outcomes Services, discusses what is driving a great focus and intensity on outcomes in clinical trials, trends coming in 2022, and the use of real-world data in the rare disease space.